Shabeeb ZA, Faraj YF, Mtashar BA, Hussein MS, Hasan AF. Immune-biomarker signature predicts early molecular response in Iraqi chronic myeloid leukemia patients receiving front-line tyrosine-kinase inhibitors. Regul. Mech. Biosyst. [Internet]. 2025Dec.2 [cited 2026Jun.24];16(4):e25197. Available from: https://medicine.dp.ua/index.php/med/article/view/1469